European Commission Responds To French Concerns On Joint HTA Cooperation Proposals
The European Commission continues to try and ease concerns EU member states have over its proposals to drive cooperation on health technology assessments and the mandatory use of joint clinical assessment reports.
You may also be interested in...
Plans from the European Commission that would oblige all EU member states to consider joint clinical assessments have come under fire from Germany, France, Poland and the Czech Republic.
Draft proposals to improve EU-wide cooperation on health technology assessments, including mandatory joint clinical assessments, have won support from EFPIA, the European Federation of Pharmaceutical Industries and Associations.
Public health advocates say that commercial concerns must take a back seat to health interests if COVID-19 technologies are to be made available to those who need them. But industry says that relaxing IP protections is not the solution and that many companies have already invested significant amounts of money in potential new treatments and vaccines.